Over the last 90 days, prior to the date of this filing, there have been 15 insider transactions reported to the SEC for Fate Therapeutics. These transactions came from the activities of 5 separate insiders that resulted in a net disposition of 561,983 company shares. In the preceding 90-day window of time, there was 1 transaction from 1 insider that culminated in the acquisition of 3,703,704 shares.
This is lower than the average level of insider transactions in the 324-company Bio Therapeutic Drugs peer group over the last 90-day period. Activity in the peer group averaged 29.5 transactions per company, with company insiders acquiring on average 13,634 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/1434316/000089924319002335/xslF345X03/doc4.xml
|Facebook Launching 'Off-Facebook Activity' Feature t...|
|--Trump Says Fed Must 'Do Its Job' And Cut Rates; Wa...|
|Xilinx SoCs Found to Carry Unpatchable Flaw|
|Update: Hasbro to Begin Phasing Out Plastic From Pro...|
|US Regulator Fines TherapeuticsMD $200,000 For Viola...|